Sun Pharmaceutical Industries Limited
SUNPHARMA
Quarterly results
Revenue and net profit
₹ crore
Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.
- Income
- ₹ crore
Sept 20266,142
Quarter ₹ crore YoY Sept 2024 5,128 +0.6% Dec 2024 6,192 +22.0% Mar 2025 7,186 +27.4% Jun 2025 5,602 +24.5% Sept 2025 4,548 -11.3% Dec 2025 5,688 -8.1% Mar 2026 4,924 -31.5% Jun 2026 5,741 +2.5% Sept 2026 6,142 +35.0% - ₹ crore
Sept 202681
Quarter ₹ crore Sept 2024 86 Dec 2024 68 Mar 2025 132 Jun 2025 104 Sept 2025 73 Dec 2025 180 Mar 2026 63 Jun 2026 140 Sept 2026 81 - ₹ crore
Sept 20266,223
Quarter ₹ crore Sept 2024 5,214 Dec 2024 6,260 Mar 2025 7,318 Jun 2025 5,706 Sept 2025 4,621 Dec 2025 5,868 Mar 2026 4,987 Jun 2026 5,881 Sept 2026 6,223 - Cost structure
- ₹ crore
Sept 2026852
Quarter ₹ crore Sept 2024 662 Dec 2024 652 Mar 2025 649 Jun 2025 715 Sept 2025 729 Dec 2025 740 Mar 2026 704 Jun 2026 831 Sept 2026 852 - ₹ crore
Sept 20265,020
Quarter ₹ crore Sept 2024 4,318 Dec 2024 4,995 Mar 2025 4,706 Jun 2025 4,233 Sept 2025 3,949 Dec 2025 4,512 Mar 2026 4,138 Jun 2026 4,363 Sept 2026 5,020 - Exceptional items and tax
- ₹ crore
Sept 20261,203
Quarter ₹ crore Sept 2024 896 Dec 2024 1,265 Mar 2025 2,612 Jun 2025 1,185 Sept 2025 672 Dec 2025 1,097 Mar 2026 849 Jun 2026 1,486 Sept 2026 1,203 - ₹ crore
Sept 2026332
Quarter ₹ crore Sept 2024 32 Dec 2024 84 Mar 2025 612 Jun 2025 431 Sept 2025 108 Dec 2025 392 Mar 2026 240 Jun 2026 371 Sept 2026 332 - Profit
- ₹ crore
Sept 2026871
Quarter ₹ crore YoY Sept 2024 863 -2.9% Dec 2024 1,181 +63.7% Mar 2025 2,000 +130.6% Jun 2025 754 +216.8% Sept 2025 564 -34.6% Dec 2025 705 -40.3% Mar 2026 609 -69.6% Jun 2026 1,115 +48.0% Sept 2026 871 +54.4% - Per share
- ₹ per share
Sept 20263.60
Quarter ₹ per share Sept 2024 3.60 Dec 2024 4.90 Mar 2025 8.30 Jun 2025 3.10 Sept 2025 2.40 Dec 2025 2.90 Mar 2026 2.50 Jun 2026 4.60 Sept 2026 3.60
| ₹ crore | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sept 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Income | |||||||||
| 5,128 | 6,192 | 7,186 | 5,602 | 4,548 | 5,688 | 4,924 | 5,741 | 6,142 | |
| Revenue YoY | +0.6% | +22.0% | +27.4% | +24.5% | -11.3% | -8.1% | -31.5% | +2.5% | +35.0% |
| 86 | 68 | 132 | 104 | 73 | 180 | 63 | 140 | 81 | |
| 5,214 | 6,260 | 7,318 | 5,706 | 4,621 | 5,868 | 4,987 | 5,881 | 6,223 | |
| Cost structure | |||||||||
| 662 | 652 | 649 | 715 | 729 | 740 | 704 | 831 | 852 | |
| 4,318 | 4,995 | 4,706 | 4,233 | 3,949 | 4,512 | 4,138 | 4,363 | 5,020 | |
| Exceptional items and tax | |||||||||
| 896 | 1,265 | 2,612 | 1,185 | 672 | 1,097 | 849 | 1,486 | 1,203 | |
| 32 | 84 | 612 | 431 | 108 | 392 | 240 | 371 | 332 | |
| Profit | |||||||||
| 863 | 1,181 | 2,000 | 754 | 564 | 705 | 609 | 1,115 | 871 | |
| Net profit YoY | -2.9% | +63.7% | +130.6% | +216.8% | -34.6% | -40.3% | -69.6% | +48.0% | +54.4% |
| Per share | |||||||||
| 3.60 | 4.90 | 8.30 | 3.10 | 2.40 | 2.90 | 2.50 | 4.60 | 3.60 | |
Latest filed period ends Sept 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 9 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.